How the body absorbs a study medicine for weight
Part of Hormones & metabolism clinical trials.
This study looks at how well a new medicine called berobenatide is absorbed into the body in adults who are overweight or have obesity. It aims to find the best way to give the medicine and may help with future weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your body mass index (BMI, a measure of body fat) is between 27 and 45.
- You weigh more than 50 kilograms (110 pounds).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have other long-term health conditions (like diabetes or heart disease).
- You do not have a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or a related genetic syndrome (MEN2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests an investigational medicine taken once a month for adults with moderate to severe sleep apnea who are overweight or have obesity and use a CPAP or similar breathing machine. It aims to see if the medicine improves sleep-related breathing.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests an investigational medicine given once a month to help Chinese adults with overweight or obesity lose weight. It is a placebo-controlled trial, meaning some participants will receive a dummy injection, and the study will compare the effects.
Hear when a new Overweight and/or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.